We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
(-8.1%)
Cap. Flow
-$941M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$293M |
| 2 |
Micron Technology
MU
|
+$214M |
| 3 |
Texas Instruments
TXN
|
+$174M |
| 4 |
Las Vegas Sands
LVS
|
+$136M |
| 5 |
SF
Stifel
SF
|
+$108M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$284M |
| 2 |
O'Reilly Automotive
ORLY
|
+$241M |
| 3 |
Arista Networks
ANET
|
+$239M |
| 4 |
Comfort Systems
FIX
|
+$218M |
| 5 |
Meta Platforms (Facebook)
META
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.74% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 13.12% |
| 4 | Industrials | 11.88% |
| 5 | Healthcare | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
876
Gencor Industries
GENC
$221M
| $324K | ﹤0.01% |
21,588
-14,229
| -40% | -$208K |
|
877
CytomX Therapeutics
CTMX
$725M
| $321K | ﹤0.01% |
+68,378
| New | +$347K |
|
878
Voya Financial
VOYA
$8.78B
| $318K | ﹤0.01% |
4,653
-15,017
| -76% | -$1.09M |
|
879
Liberty Latin America Class C
LILAK
$1.49B
| $307K | ﹤0.01% |
38,308
-108,870
| -74% | -$777K |
|
880
Travelzoo
TZOO
$103M
| $307K | ﹤0.01% |
51,782
-53,572
| -51% | -$326K |
|
881
SkinHealth Systems
SKIN
$95.9M
| $306K | ﹤0.01% |
343,559
-259,051
| -43% | -$318K |
|
882
TJX Companies
TJX
$170B
| $304K | ﹤0.01% |
1,901
-14,070
| -88% | -$2.19M |
|
|
PSIX
883
Power Solutions International
PSIX
$723M
| $300K | ﹤0.01% |
4,922
-6,627
| -57% | -$473K |
|
|
AIV
884
Aimco
AIV
$380M
| $294K | ﹤0.01% |
+72,167
| New | +$378K |
|
885
Builders FirstSource
BLDR
$7.59B
| $292K | ﹤0.01% |
3,550
-36,968
| -91% | -$3.95M |
|
886
Carriage Services
CSV
$599M
| $291K | ﹤0.01% |
6,379
-531
| -8% | -$23.1K |
|
887
OP Bancorp
OPBK
$220M
| $283K | ﹤0.01% |
21,282
+2,923
| +16% | +$40.2K |
|
888
Jasper Therapeutics
JSPR
$24.3M
| $282K | ﹤0.01% |
322,273
+267,473
| +488% | +$371K |
|
889
DexCom
DXCM
$27.2B
| $280K | ﹤0.01% |
4,466
-7,096
| -61% | -$494K |
|
890
Capitol Federal Financial
CFFN
$1.06B
| $276K | ﹤0.01% |
38,721
| – | – |
|
891
Verisk Analytics
VRSK
$25.3B
| $274K | ﹤0.01% |
1,445
-14,828
| -91% | -$3.01M |
|
892
Protara Therapeutics
TARA
$227M
| $262K | ﹤0.01% |
+50,255
| New | +$297K |
|
893
Graham Holdings Company
GHC
$4.92B
| $260K | ﹤0.01% |
246
-652
| -73% | -$719K |
|
894
Biohaven
BHVN
$2.21B
| $254K | ﹤0.01% |
+30,080
| New | +$329K |
|
895
Resideo Technologies
REZI
$5.16B
| $254K | ﹤0.01% |
7,546
-136
| -2% | -$4.86K |
|
896
Moelis & Co
MC
$4.88B
| $247K | ﹤0.01% |
4,340
-335
| -7% | -$21.8K |
|
897
PCB Bancorp
PCB
$411M
| $247K | ﹤0.01% |
10,979
-2,233
| -17% | -$49.9K |
|
898
PepsiCo
PEP
$184B
| $247K | ﹤0.01% |
+1,588
| New | +$247K |
|
899
Doximity
DOCS
$3.68B
| $244K | ﹤0.01% |
10,457
-73,276
| -88% | -$2.28M |
|
900
Seer Inc
SEER
$113M
| $241K | ﹤0.01% |
143,242
+104,226
| +267% | +$193K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2026 Portfolio in Review
As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.
- Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
- Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
- Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
- Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
- Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.